Trends of hepatitis A hospitalizations and costs associated with the hospitalization in Spain (2000-2005)

Journal of Viral Hepatitis

Volumn 16, Issue 4, 2009, Pages 286-291

  Arteaga, A ^a   Carrasco Garrido, P ^a   De Andres, A L ^a   De Miguel, A G ^a   Jimenez Garcia R ^a,b  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b Facultad de Ciencias de la Salud   (Spain)

Author keywords

Burden; Epidemiology; Hepatitis A; Hospitalizations

Indexed keywords

ADULT; ARTICLE; CALCULATION; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DEATH; FEMALE; HEPATITIS A; HOSPITAL ADMISSION; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; INFORMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPAIN;

ADULT; AGE FACTORS; AGED; ANIMALS; COMORBIDITY; FEMALE; HEALTH CARE COSTS; HEPATITIS A; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; SPAIN; YOUNG ADULT;

EID: 61449122189     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01075.x     Document Type: Article

References (26)

1. Meyerhoff AS, Jacobs RJ. Transmission of hepatitis A through household contact. J Viral Hepat 2001 8 (6 454 458.
2. Koslap-Petraco MB, Shub M, Judelsohn R. Hepatitis A. disease burden and current childhood vaccination strategies in the United States. J Pediatr Health Care 2008 22 (1 3 11.
3. World Health Organization. Hepatitis A. Department of Communicable Disease Surveillance and Response. Available at: http://www.who.int/csr/disease/ hepatitis/en/HepatitisA-whocdscsredc2000-7.pdf (accessed 20 June 2008).
4. Wasley A, Miller JT, Finelli L Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis - United States, 2005. MMWR Surveill Summ 2007 56 (3 1 24.
5. Wasley A, Grytdal S, Gallagher K Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis - United States, 2006. MMWR Surveill Summ 2008 57 (2 1 24.
6. Junquera S, Mateos M, Lasa E, Chacón J, Baquero F. Seroepidemiologic study of hepatitis A in the community of Madrid during the year 2002. Enferm Infecc Microbiol Clin 2004 22 (8 448 451.
7. The prevalence of hepatitis A in the Guadalajara province. Is Spain a country with low endemia? Enferm Infecc Microbiol Clin 2001 19 (9 428 431.
8. Santana OE, Rivero LE, Limiñana JM, Hernández LA, Santana M, Martín AM. Seroepidemiological study of hepatitis A in Gran Canaria (Spain). Enferm Infecc Microbiol Clin 2000 18 (4 170 173.
9. Velasco ML, Cano R. Centro Nacional de Epidemiología. Instituto de Salud Carlos III. Vigilancia de hepatitis A, España. Años 1997-2000. Bol Epidemiol Semana 2001 9 : 139.
10. Bonanni P, Boccalini S, Bechini A EUROHEP.NET Team. Measurement and reporting of burden of disease for hepatitis A: results of the EUROHEP.NET feasibility survey. Eur J Public Health 2007 17 (1 69 74.
11. Bialek SR, Thoroughman DA, Hu D et al. Hepatitis A incidence and hepatitis A vaccination among American Indians and Alaska Natives, 1990-2001. Am J Public Health 2004 94 (6 996 1001.
12. Amon JJ, Darling N, Fiore AE, Bell BP, Barker LE. Factors associated with hepatitis A vaccination among children 24 to 35 months of age: United States, 2003. Pediatrics 2006 117 (1 30 33.
13. Wasley A, Flore A, Bell BP. Hepatitis A in the era of vaccination. Epidemiol Rev. 2006 28 (1 101 111.
14. American Academy of Pediatrics Committee on Infectious Diseases. Hepatitis A vaccine recommendations. Pediatrics 2007 120 (1 189 199.
15. Conjunto Mínimo Básico de Datos. Hospitales del INSALUD. Available at: http://www.ingesa.msc.es/estadEstudios/documPublica/CMBD-2001.htm (accessed 20 June 2008).
16. Clasificación Internacional de Enfermedades 9 revisión, modificación clínica. Edición electrónica de la CIE-9-MC, 5 edición (2006). Versión 2.2.03. Available at: http://www.msc.es/estadEstudios/ecie9mc/webcie9mc/webcie9mc.htm (accessed 20 June 2008).
17. Instituto Nacional de Estadística (INE). Population Estimates. Available at: http://www.ine.es (accessed 20 June 2008).
18. Instituto Nacional de la Salud. Ministerio de Sanidad y Consumo. CMBD Insalud. Análisis de los GRDs. Año 2000. Available at: http://www.ingesa.msc.es/estadEstudios/documPublica/cmbd2000.htm (accessed 20 June 2008).
19. Centro Nacional de Epidemiología (CNE). Instituto de Salud Carlos III. Available at: http://www.isciii.es/jsps/centros/epidemiologia/ procedimientos.jsp (accessed 20 June 2008).
20. Canuel M, De Serres G, Duval B, Gilca R, De Wals P, Gilca V. Trends of hepatitis A hospitalization and risk factors in Quebec, Canada, between 1990 and 2003. BMC Infect Dis 2007 7 : 31.
21. Ministerio de Sanidad y Consumo. Vacunación en Adultos. Recomendaciones año 2004. Subdirección General de Promoción de la Salud y Epidemiología. Madrid : Ministerio de Sanidad y Consumo, 2004.
22. Lieberman J, Word B, Jacobs R, Dagan R, Marchant C. Universal hepatitis A vaccination in the United States: a call for action. Pediatr Infect Dis J 2008 27 (4 287 291.
23. Bauch CT, Anonychuk AM, Pham BZ, Gilca V, Duval B, Krahn MD. Cost-utility of universal hepatitis A vaccination in Canada. Vaccine 2007 25 (51 8536 8548.
24. Oviedo M, Muñoz MP, Domínguez A, Carmona G. Estimated incidence of HAV infection in Catalonia. Ann Epidemiol 2006 16 (11 812 819.
25. Lema Devesa MC. Economics, health, and health care. Neurologia 2003 18 (Suppl. 4 57 63.
26. Librero J, Peiró S, Ordiñana R. Chronic comorbidity and homogeneity in diagnostic related groups. Gac San 1999 13 (4 292 302.